Value of Mesothelin Immunostaining in the Diagnosis of Mesothelioma

Brown, 1997, Immunohistochemical identification of tumor markers in metastatic adenocarcinoma: a diagnostic adjunct in the determination of primary site, Am J Clin Pathol, 107, 12, 10.1093/ajcp/107.1.12

Ordóñez, 1989, The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma, Am J Surg Pathol, 13, 276, 10.1097/00000478-198904000-00003

Ordóñez, 1997, Value of antibodies 44–3A6, SM3, HBME-1 and thrombomodulin in differentiating epithelial pleural mesothelioma from lung adenocarcinoma: a comparative study with other commonly used antibodies, Am J Surg Pathol, 21, 1399, 10.1097/00000478-199712000-00002

Riera, 1997, The immunohistochemical diagnostic panel for epithelial mesothelioma. A reevaluation after heat-induced epitope retrieval, Am J Surg Pathol, 21, 1409, 10.1097/00000478-199712000-00003

Amin, 1995, Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma, Am J Pathol, 146, 344

Clover, 1997, Anti-cytokeratin 5/6. A positive marker for epithelioid mesothelioma, Histopathology, 31, 140, 10.1046/j.1365-2559.1997.2150833.x

Collins, 1992, Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma, Am J Pathol, 141, 827

Doglioni, 1996, Calretinin. A novel immunocytochemical marker for mesothelioma, Am J Surg Pathol, 20, 1037, 10.1097/00000478-199609000-00001

Ordóñez, 1998, In search of a positive immunohistochemical marker for mesothelioma: an update, Adv Anat Pathol, 5, 53, 10.1097/00125480-199801000-00051

Ordóñez, 2000, Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma, Am J Surg Pathol, 24, 598, 10.1097/00000478-200004000-00016

Carella, 2001, Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: a study with logistic regression analysis, Am J Surg Pathol, 25, 43, 10.1097/00000478-200101000-00004

Ordóñez, 1998, Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma, Mod Pathol, 11, 929

Chang, 1992, Monoclonal antibody K1 reacts with epithelial mesothelioma but not with lung adenocarcinoma, Am J Surg Pathol, 16, 259, 10.1097/00000478-199203000-00006

Travis, 1999, World Health Organization international histological classification of tumors: histologic typing of lung and pleural tumors

Ordóñez NG . The immunohistochemical diagnosis of epithelioid mesotheliomas: old markers, new markers—a critical review. Hum Pathol (in press).

Chang, 1992, Characterization of the antigen (CAK1) recognized by monoclonal antibody K1 present on ovarian cancers and normal mesothelium, Cancer Res, 52, 181

Chang, 1992, Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium, Int J Cancer, 50, 373, 10.1002/ijc.2910500308

Chang, 1996, Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers, Proc Natl Acad Sci U S A, 93, 136, 10.1073/pnas.93.1.136

Kojima, 1995, Molecular cloning and expression of megakaryocyte potentiating factor cDNA, J Biol Chem, 270, 21984, 10.1074/jbc.270.37.21984

Argani, 2001, Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE), Clin Cancer Res, 7, 3862

Chang, 1992, Frequent expression of the tumor antigen CAK1 in squamous-cell carcinomas, Int J Cancer, 51, 548, 10.1002/ijc.2910510408